経営者に聞く 株式会社立松鉄工 代表取締役社長 鎌田保夫氏
Published in Medical Entomology and Zoology • Oct 1, 2008
Authors:,
保夫 鎌田
伸二 牧野
Abstract
Insertion of HS in prostate cancer patients receiving combined HDR and EBRT is safe and has resulted in a significant radiation dose reduction to the rectum, resulting in significantly less acute GI toxicity and a trend towards less late GI toxicity.
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!